Oncothera Advocacy Joins the Australian Patient Advocacy Alliance (APAA)

Oncothera Advocacy is proud to announce that we have joined the Australian Patient Advocacy Alliance (APAA) as a member organisation, marking another important milestone in our commitment to supporting patients and advancing the future of theranostics in Australia.

As Australia's independent voice for theranostics, we believe that collaboration is essential to improving patient awareness, education and access to innovative healthcare. Joining APAA strengthens our ability to work alongside leading patient advocacy organisations from across the country, united by a shared goal of ensuring the patient voice remains at the centre of healthcare.

Strengthening the Patient Voice

The Australian Patient Advocacy Alliance is a national network of patient organisations that works to promote patient-centred healthcare and encourage meaningful engagement between patients, healthcare professionals, researchers, policymakers and the broader health sector.

By bringing together organisations representing a wide range of diseases and healthcare priorities, APAA provides an important platform for collaboration, knowledge sharing and collective advocacy. This collaborative approach helps ensure that patient perspectives are considered in conversations about healthcare policy, service delivery, research and innovation.

For Oncothera Advocacy, becoming part of this network represents an exciting opportunity to contribute to broader discussions that influence the future of healthcare in Australia.

Supporting Patients Through Education and Awareness

At Oncothera Advocacy, our mission extends beyond raising awareness of theranostics. We are committed to providing balanced, evidence-informed educational resources that help patients, families and healthcare professionals better understand precision medicine, radiopharmaceuticals and the evolving role of theranostics in cancer care.

Through trusted information, educational initiatives and partnerships across the healthcare ecosystem, we aim to empower patients to have informed conversations with their healthcare teams while supporting greater understanding of this rapidly advancing field.

Joining APAA complements this mission by creating new opportunities to collaborate with organisations that share our commitment to improving patient outcomes through education, advocacy and engagement.

Looking Ahead

As the field of theranostics continues to evolve, meaningful progress will depend on collaboration across the entire healthcare community – including patients, advocacy organisations, clinicians, researchers, industry and government.

We look forward to working alongside APAA and its member organisations to exchange knowledge, support patient-centred initiatives and help strengthen awareness of theranostics throughout Australia.

Together, we can help create a more informed, connected and patient-focused healthcare system – one where every patient has access to trusted information, meaningful support and the opportunity to benefit from advances in precision medicine.

We are excited to begin this new chapter with APAA and look forward to the opportunities that lie ahead.